The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development

Regulatory Peptides

Volumn 162, Issue 1-3, 2010, Pages 52-60

  Kidd, M ^a   Siddique, Z L ^a   Drozdov, I ^a   Gustafsson, B I ^a,b   Camp, R L ^a   Black, J W ^a   Boyce, M ^a   Modlin, I M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

CCK2 receptor; ECL cell; Gastrin; Mastomys; Neuroendocrine; Proliferation; Tumor

Indexed keywords

1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2 PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 [3 (METHYLAMINO)PHENYL]UREA; CHOLECYSTOKININ B RECEPTOR; CHROMOGRANIN A; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN D1; HISTAMINE; HISTIDINE DECARBOXYLASE; LOXTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; DRUG TARGETING; ENTEROCHROMAFFIN LIKE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HISTOPATHOLOGY; HYPERGASTRINEMIA; LONG TERM CARE; MALE; MASTOMYS; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STOMACH ACID SECRETION; STOMACH CARCINOID; TUMOR VOLUME;

ANIMALS; BENZODIAZEPINONES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERPLASIA; MALE; MURINAE; PHENYLUREA COMPOUNDS; POLYMERASE CHAIN REACTION; RECEPTOR, CHOLECYSTOKININ B; SEROTONIN; STOMACH NEOPLASMS;

ANIMALIA; MASTOMYS; RODENTIA; SIGMODON;

EID: 77952673178     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.01.009     Document Type: Article

References (39)

1. Modlin I., Sachs G. Acid related diseases: biology and treatment 2004, Lippincott, Williams and Wilkins, Philadelphia.
2. Kidd M., Modlin I.M., Tang L.H. Gastrin and the enterochromaffin-like cell: an acid update. Dig Surg 1998, 15:209-217.
3. Axelson J., Persson P., Gagnemo-Persson R., Hakanson R. Importance of the stomach in maintaining calcium homoeostasis in the rat. Gut 1991, 32:1298-1302.
4. Modlin I., Tang L. The gastric enterochromaffin-like cell: an enigmatic cellular link. Gastroenterology 1996, 111:783-810.
5. Nilsson O., Wängberg B., McRae A., et al. Growth factors and carcinoid tumours. Acta Oncol 1993, 32:115-124.
6. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986, 35(Suppl 1):42-55.
7. Havu N., Mattsson H., Ekman L., Carlsson E. Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. Digestion 1990, 45:189-195.
8. Bilchik A.J., Nilsson O., Modlin I.M., Sussman J., Zucker K.A., Adrian T.E. H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in Mastomys. Surgery 1989, 106:1119-1126. discussion 026-7.
9. Ekman L., Hansson E., Havu N., Carlsson E., Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985, 20:53-69.
10. Tang L.H., Luque E.A., Efstathiou J.A., Bortecen K.H., Kidd M., Tarasova N.I., Modlin I.M. Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent. Regul Pept 1997, 72:9-18.
11. Waldum H.L., Rorvik H., Falkmer S., Kawase S. Neuroendocrine (ECL cell) differentiation of spontaneous gastric carcinomas of cotton rats (Sigmodon hispidus). Lab Anim Sci 1999, 49:241-247.
12. Fossmark R., Martinsen T.C., Bakkelund K.E., Kawase S., Waldum H.L. ECL-cell derived gastric cancer in male cotton rats dosed with the H2-blocker loxtidine. Cancer Res 2004, 64:3687-3693.
13. Chiba T., Kinoshita Y., Sawada M., Kishi K., Baba A., Hoshino E. The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041R. Yale J Biol Med 1998, 71:247-255.
14. Tang L.H., Modlin I.M., Lawton G.P., Kidd M., Chinery R. The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent Mastomys. Gastroenterology 1996, 111:1212-1223.
15. Kidd M., Modlin I.M., Eick G.N., Camp R.L., Mane S.M. Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development. Am J Physiol Gastrointest Liver Physiol 2007, 292:G191-G200.
16. Kidd M., Hinoue T., Eick G., Lye K.D., Mane S.M., Wen Y., Modlin I.M. Global expression analysis of ECL cells in Mastomys natalensis gastric mucosa identifies alterations in the AP-1 pathway induced by gastrin-mediated transformation. Physiol Genomics 2004, 20:131-142.
17. Modlin I.M., Kumar R.R., Soroka C.J., Ahlman H., Nilsson O., Goldenring J.R. Histamine as an intermediate growth factor in genesis of gastric ECLomas associated with hypergastrinemia in Mastomys. Dig Dis Sci 1994, 39:1446-1453.
18. Kolby L., Wangberg B., Ahlman H., Modlin I., Granerus G., Theodorsson E., Nilsson O. Histidine decarboxylase expression and histamine metabolism in gastric oxyntic mucosa during hypergastrinemia and carcinoid formation. Endocrinology 1996, 137:4435-4442.
19. Modlin I.M., Zhu Z., Tang L.H., Kidd M., Lawton G.P., Miu K., Powers R.E., Goldenring J.R., Pasikhov D., Soroka C.J. Evidence for a regulatory role for histamine in gastric enterochromaffin-like cell proliferation induced by hypergastrinemia. Digestion 1996, 57:310-321.
20. Semple G., Ryder H., Rooker D.P., Batt A.R., Kendrick D.A., Szelke M., Ohta M., Satoh M., Nishida A., Akuzawa S., Miyata K. (3R)-N-(1-(tert-butylcarbonylmethyl)-2, 3-dihydro-2-oxo-5-(2-pyridyl)-1H-1, 4-benzo diazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist. J Med Chem 1997, 40:331-341.
21. Takinami Y., Yuki H., Nishida A., Akuzawa S., Uchida A., Takemoto Y., Ohta M., Satoh M., Semple G., Miyata K. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo. Aliment Pharmacol Ther 1997, 11:113-120.
22. Kitano M., Norlen P., Ding X.Q., Nakamura S., Hakanson R. Long-lasting cholecystokinin2 receptor blockade after a single subcutaneous injection of YF476 or YM022. Br J Pharmacol 2000, 130:699-705.
23. Black J.W., Kalindjian S.B. Gastrin agonists and antagonists. Pharmacol Toxicol 2002, 91:275-281.
24. Kidd M., Modlin I.M., Black J.W., Boyce M., Culler M. A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regul Pept 2007, 143:109-117.
25. Fykse V., Sandvik A.K., Waldum H.L. One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release. Scand J Gastroenterol 2005, 40:1269-1274.
26. Lindstrom E., Bjorkqvist M., Boketoft A., Chen D., Zhao C.M., Kimura K., Hakanson R. Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells. Regul Pept 1997, 71:73-86.
27. Kayahara T., Sawada M., Takaishi S., Fukui H., Seno H., Fukuzawa H., Suzuki K., Hiai H., Kageyama R., Okano H., Chiba T. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett 2003, 535:131-135.
28. Martinsen T.C., Kawase S., Hakanson R., Torp S.H., Fossmark R., Qvigstad G., Sandvik A.K., Waldum H.L. Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist. Carcinogenesis 2003, 24:1887-1896.
29. Kidd M., Modlin I., Eick G., Champaneria M. Isolation, purification and functional characterization of the Mastomys EC cell. Am J Physiol 2006, 291:G778-G791.
30. Modlin I.M., Esterline W., Kim H., Goldenring J.R. Enterochromaffin-like cells and gastric argyrophil carcinoidosis. Acta Oncol 1991, 30:493-498.
31. Kidd M., Tang L.H., Modlin I.M., Zhang T., Chin K., Holt P.R., Moss S.F. Gastrin-mediated alterations in gastric epithelial apoptosis and proliferation in a Mastomys rodent model of gastric neoplasia. Digestion 2000, 62:143-151.
32. Kidd M., Modlin I., Gustafsson B., Drozdov I., Hauso O., Pfragner R. The luminal regulation of normal and neoplastic EC cell serotonin release is mediated by bile salts, amines, tastants and olfactants. Am J Physiol 2008, 295:G260-G272.
33. Kidd M., Eick G., Shapiro M.D., Camp R.L., Mane S.M., Modlin I.M. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors. Cancer 2005, 103:229-236.
34. Kidd M., Nadler B., Mane S.M., Eick G.N., Malfertheiner M.V., Champaneria M.C., Pfragner R., Modlin I.M. GeneChip, geNorm and gastrointestinal tumors: novel reference genes for real-time PCR. Physiol Genomics 2007, 30:363-370.
35. R: A Language and Environment for Statistical Computing 2008, R Foundation for Statistical Computing, Vienna, Austria.
36. Kidd M., Tang L.H., Schmid S.W., Miu K., Modlin I.M. A polyamine pathway-mediated mitogenic mechanism in enterochromaffin-like cells of Mastomys. Am J Physiol 1998, 275:G370-G376.
37. Gronstad K.O., Zinner M.J., Nilsson O., Dahlstrom A., Jaffe B.M., Ahlman H. Vagal release of serotonin into gut lumen and portal circulation via separate control mechanisms. J Surg Res 1988, 44:146-151.
38. D'Adda T., Pilato FP Sivelli R., Azzoni C., Sianesi M., Bordi C. Gastric carcinoid tumor and its precursor lesions. Ultrastructural study of a case before and after antrectomy. Arch Pathol Lab Med 1994, 118:658-663.
39. Mills J., Syder A., Hong C., Guruge J., Raail F., Gordon J. A molecular profile of the mouse gastric parietal cell with and without exposure to Helicobacter pylori. Proc Natl Acad Sci U S A 2001, 98:13687-13692.